Catalyst Pharmaceuticals, Inc. (CPRX) NASDAQ

20.84

-0.005(-0.02%)

Updated at October 03 04:00PM

Currency In USD

Valuation

Market Cap2.47B
Enterprise Value1.96B
P/E Ratio12.2
PEG Ratio2.53
Price/Sales Ratio4.57
Price/Book Ratio2.97
Enterprise/Revenue3.4
Enterprise/EBITDA6.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.37
Operating Margin0.44

Management Effectiveness

Return On Assets0.21
Return On Equity0.27

Income Statement

Revenue491.73M
Revenue/Share4.57
Gross Profit422.89M
EBITDA232.9M
Net Income163.89M
Diluted EPS1.31

Balance Sheet

Total Cash652.8M
Total Cash/Share5.34
Total Debt2.99M
Total Debt/Equity0
Current Ratio6.71
Book Value Per Share7.01

Price History

52-Week Change4.2
52-Week High26.58
52-Week Low19.05
Moving Average 50 Days20.34
Moving Average 200 Days22.15

Statistics

Average Volume1.54M
Shares Outstanding122.39M
% Held by Institutions82.99

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A